Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Salfaprodil after intravenous thrombolysis for acute ischemic stroke
ChiCTR2200059163Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salfaprodil in ischemic stroke (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: modified Rankin Scale score. Started Oct 2020; status: recruiting.
02
Drugs
salfaprodil
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200059163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059163.